Rabeprazole Sodium & Levosulpiride Sustain Release Capsules 20mg+75mg Technical Specification:
| Product Name: | Rabeprazole Sodium & Levosulpiride Sustain Release Capsules 20mg+75mg |
| Brand Name: | Generics |
| Strength: | (20mg+75mg) |
| Dosage Form: | Capsule (Hard-gelatine) |
| Route of Administration: | Via Oral Route |
| Packing: | 10s, 30s, 100s |
| Pack Insert/Leaflet: | PIL (Patient Information Leaflet) |
| Documents: | COA, MOA, Stability Studies, GMP |
| Therapeutic use: | Anti-Ulcer, |
| Indication: | LEVOSULPIRIDE+RABEPRAZOLE belongs to a group of medicines called gastrointestinal agents used to treat gastroesophageal reflux disease (GERD), acidity, heartburn, Zollinger-Ellison syndrome, Helicobacter pylori infection, irritable bowel syndrome, indigestion, duodenal and gastric ulcers. |
| Storage: | Store below 30°C. Protect from Light and moisture. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
- Rabeprazole Sodium & Levosulpiride Sustain Release Capsules 20mg+75mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
- Rabeprazole Sodium & Levosulpiride Sustain Release Capsules 20mg+75mg
Each hard gelatin capsule contains:
Rabeprazole Sodium IP…………………….20mg
(enteric-coated pellets)
Levosulpiride………………………75mg
(as sustained release tablet)
Excipients………………………………………q.s.
Colours: Ferric oxide (Red)USP-NF, Titanium Dioxide IP
Approved colour used in capsule shells.
THERAPEUTIC INDICATIONS:
LEVOSULPIRIDE+RABEPRAZOLE belongs to a group of medicines called gastrointestinal agents used to treat gastroesophageal reflux disease (GERD), acidity, heartburn, Zollinger-Ellison syndrome, Helicobacter pylori infection, irritable bowel syndrome, indigestion, duodenal and gastric ulcers.
CAUTION & SCHEDULE:
CAUTION:
Read enclosed leaflet before use.
Keep medicine out of reach of children.
SWALLOW WHOLE DO NOT CHEW OR CRUSH
SCHEDULE: SCHEDULE H: NOT TO BE SOLD BY RETAIL WITHOUT THE PRESCRIPTION OF A REGISTERED MEDICAL PRACTITIONER.
STORAGE & DOSAGE:
Storage: Store below 30°C. Protect from Light and moisture.
Dosage: As directed by the Physician.
GENERIC NAME OF THE MEDICINAL PRODUCT:
A. Rabeprazole Sodium & Levosulpiride Sustain Release Capsules 20mg+75mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
A) Rabeprazole Sodium & Levosulpiride Sustain Release Capsules 20mg+75mg
Each hard gelatin capsule contains:
Rabeprazole Sodium IP…………………….20mg
(enteric coated pellets)
Levosulpiride………………………75mg
(as sustained release tablet)
Excipients………………………………………q.s.
Colours: Ferric oxide (Red)USP-NF, Titanium Dioxide IP
Approved colour used in capsule shells.
Each hard gelatin capsule contains:
Rabeprazole Sodium IP…………………….20mg
(enteric coated pellets)
Levosulpiride………………………75mg
(as sustained release tablet)
Excipients………………………………………q.s.
Colours: Ferric oxide (Red)USP-NF, Titanium Dioxide IP
Approved colour used in capsule shells.
THERAPEUTIC INDICATIONS:
LEVOSULPIRIDE+RABEPRAZOLE belongs to a group of medicines called gastrointestinal agents used to treat gastro-esophageal reflux disease (GERD), acidity, heartburn, Zollinger-Ellison syndrome, Helicobacter pylori infection, irritable bowel syndrome, indigestion, duodenal and gastric ulcers.
CAUTION & SCHEDULE:
CAUTION:
Read enclosed leaflet before use.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
SWALLOW WHOLE DO NOT CHEW OR CRUSH
SCHEDULE: SCHEDULE H: NOT TO BE SOLD BY RETAIL WITHOUT THE PRESCRIPTION OF A REGISTERED MEDICAL PRACTITIONER.
Read enclosed leaflet before use.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
SWALLOW WHOLE DO NOT CHEW OR CRUSH
SCHEDULE: SCHEDULE H: NOT TO BE SOLD BY RETAIL WITHOUT THE PRESCRIPTION OF A REGISTERED MEDICAL PRACTITIONER.
STORAGE & DOSAGE:
Storage: Store below 30°C. Protect from Light and moisture.
Dosage: As directed by the Physician
Dosage: As directed by the Physician
